KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Shares Outstanding (Weighted Average) (2016 - 2025)

Incyte (INCY) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $195.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) fell 5.75% year-over-year to $195.2 million, compared with a TTM value of $195.2 million through Dec 2025, down 5.75%, and an annual FY2025 reading of $195.2 million, down 5.75% over the prior year.
  • Shares Outstanding (Weighted Average) was $195.2 million for Q4 2025 at Incyte, roughly flat from $194.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $224.5 million in Q1 2024 and bottomed at $193.7 million in Q1 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $215.1 million, with a median of $220.9 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 1.42% in 2021, then fell 13.71% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $220.4 million in 2021, then increased by 0.71% to $222.0 million in 2022, then grew by 0.73% to $223.6 million in 2023, then fell by 7.39% to $207.1 million in 2024, then dropped by 5.75% to $195.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for INCY at $195.2 million in Q4 2025, $194.5 million in Q3 2025, and $193.9 million in Q2 2025.